TGFB1 and muscle atrophy: Collectively, our results suggest that the blockade of the AT1 receptor with losartan has beneficial effects in disuse-induced skeletal muscle atrophy in female rats by preventing canonical TGF-β signaling, and provide insight into novel treatment strategies against muscle wasting in females.